AI GxP validation for regulated life sciences
ISO 9001 certifiedQuality managementISO/IEC 27001 certifiedInformation security
AI-enabled GxP validation and compliance

AI-native validation for life sciences.

GxP Copilot drafts the full validation package from your requirements. Our experts and your team review and sign. Inspection-ready in weeks, not months.

Human review at every gateExplore GxP CopilotExpert services
GxP Copilot document engine showing an approved initial risk assessment
Part 11 audit trailHash-chained, tamper-evident
Drafted from your URSEvery section reviewed
E-signature gatesNamed reviewer, every step

Trusted by life sciences teams worldwide

GSK
Karolinska Institutet
Mercy Health
3Analytics
TriDS Validation
Excelra
Ceban Pharmaceuticals
Prothiya
Batavia Biosciences
Codern Pharma
Hexaware
Inside GxP Copilot

See it working

Real screenshots from GxP Copilot — the validation portfolio dashboard, built-in document engine, tamper-evident audit trail, and AI assistant that knows your regulatory context.

GxP Copilot validation portfolio dashboardGxP Copilot document viewer showing an approved initial risk assessmentGxP Copilot tamper-evident audit trailAsk GxP assistant answering a regulatory question
GxP Copilot validation portfolioLive inspection readiness, AI assistant, and systems tracked at a glance.
The validation lifecycle

From URS to a signed package, in one workflow.

See where every system stands at a glance. The AI drafts, your people decide. Select a step to see what happens in it.

Drafted by GxP Copilot
Reviewed and signed by your team, with a full audit trail
Step 1 of 6: RequirementsWhat GxP Copilot produces

A requirement register with an ID for every requirement.

 What your team decides

Your validation lead confirms the requirements and which ones are GxP-relevant.

Why teams switch

Getting Validated Shouldn't Feel Like A Guessing Game

Without the right operating model, shipping compliant systems and regulator-ready documents is slow, expensive and uncertain. Too often, Life Sciences teams face:

  • Slow, manual validation cycles
  • Documentation bottlenecks at submission
  • Traceability that goes stale
  • AI pilots that never reach production
Manual validationWeeks
URS reviewRiskTest scriptsExecutionTraceabilityReport
With GxP CopilotDays

Drafting, tests, traceability and report generated in one pass, then reviewed.

Hand-written documentsAI-drafted, human-reviewed

Illustrative comparison. Real time depends on system size, scope and how quickly your reviewers turn work around.

Products

Stop Guessing. Ship Validated.

Four AI-native platforms, purpose-built for regulated Life Sciences, with human review and approval at every step.

Validation AI

GxP Copilot

Ship inspection-ready GxP systems in a fraction of the time — with the full validation package drafted for you, risk sized to reality, and Part 11 posture baked in from day one.

  • Faster time-to-validated. A full GAMP 5 validation package drafted in days, not quarters — freeing your team to focus on judgment calls, not document assembly.
  • CSA-first, not CSA-flavoured. Test rigor scales to real per-requirement risk under FDA CSA, so you spend effort where it changes the outcome and defensibly reduce it everywhere else.
  • Inspection-ready by design. Tamper-evident audit trail, real Part 11 electronic signatures, and live traceability — the posture regulators expect, without a remediation project.
GxP Copilot validation portfolio dashboard
Clinical AI

TraceDraft

Turn writer capacity into a strategic advantage — AI-assisted clinical documents where every sentence traces back to the source data, with the compliance evidence attached on export.

  • Every claim traces to source. Not summaries, not vibes — a defensible link from every sentence back to the underlying AE listing row, dataset value or protocol clause.
  • Real 21 CFR Part 11 posture. Tamper-evident audit trail and real electronic signatures, so AI-assisted writing meets the same regulatory bar as human writing.
  • Bring your own AI. The AI provider is swappable. Start today; move to a preferred model tomorrow — without touching your workflows or SOPs.
TraceDraft approved safety narrative
Services

Solutions Built Around Your Operating Model

Five practice areas, delivered by leads who have shipped inspection-ready systems in FDA, EMA, MHRA, PMDA and CDSCO environments.

Challenges

Common Challenges We Solve

Slow validation cycles, documentation bottlenecks, stale traceability and stalled AI adoption all limit how fast a Life Sciences business can move.

01Validation cycles that take quarters, not weeks

Legacy CSV practice defaults every requirement to scripted testing, inflating effort and delaying every go-live.

02Clinical writing capacity is the binding constraint

CSR, protocol and safety-narrative throughput is limited by writer headcount, not by data availability.

03AI adoption stalled by unclear assurance posture

Teams have GenAI pilots they cannot promote to production because Annex 22 / Part 11 posture is undefined.

04Traceability that goes stale the moment it's exported

Static RTM spreadsheets can't answer coverage-gap or inspection-readiness questions on demand.

Results

Client Success Stories

Real engagements. Client names are kept private.

Biotech · LIMS validation

Full validation package for a first regulated LIMS

A Series-B biotech with no QA function, eight weeks from go-live.

Read the case study →
4 wkEnd-to-end delivery
1 hr/dayCTO time for weeks 1–2
PassedPharma-partner audit, first time
Part 11Signatures in place at go-live
We had no dedicated QA function and could not absorb a twelve-month incumbent rollout. Cybroscape delivered a complete validation package for our LIMS deployment inside a month, and we were Part 11 posture at go-live.
Head of QualitySeries-B Biotech
Writer capacity was our ceiling on CSR turnaround. TraceDraft changed the constraint — and the provenance trail meant our sponsors were comfortable with AI-assisted authoring from the first study.
VP Clinical OperationsMid-cap CRO
Your estate

Inspection-Ready, Tailored To Your Estate

We design validation and clinical documentation systems that fit the estate you actually run — SAP, LIMS, MES, SCADA, eQMS, RIM — and the regulators you actually answer to. Our solutions scale test rigor to real risk, so you spend effort where it changes the outcome and nowhere else.

SAPLIMSMESSCADAeQMSRIM
GxP
Copilot
21 CFR Part 11: Signatures record the signer, the time and what the signature means, with re-authentication at signing. The audit trail is append-only and hash-chained.
Why Cybroscape

Why Choose Us?

We take the complexity out of GxP validation, compliance and clinical documentation, helping Life Sciences teams build systems that hold up under inspection.

Deep Life Sciences Expertise

Our leads have shipped inspection-ready validation packages and clinical documentation platforms across FDA, EMA, MHRA, PMDA and CDSCO regulated environments — pharma, biotech, med-device, CRO and diagnostics.

Compliance Is Never A Trade-Off

Real 21 CFR Part 11 electronic signatures with re-authentication, tamper-evident audit trails, enforced segregation of duties, and EU Annex 11 / Annex 22 posture included by design — not bolted on later.

Product Plus Delivery

You get the AI platform and the team that runs it. No vendor-to-consultant hand-off, no finger-pointing. From first assessment through managed operations, one accountable partner.

Getting started

Ship Validated Systems Without The Guesswork

From first conversation to inspection-ready output, the path is short and the evidence is attached at every step.

01

Book a demo

Tell us about your system and timeline. We will say honestly whether we are a fit.

Step 1
02

See it on your own data

Bring a real URS or an AE listing. We run GxP Copilot or TraceDraft against it live and show you the draft, the risks and the traceability.

Step 2
03

Review, sign, ship

Your team reviews and signs. Our validation leads support every gate until go-live, with the evidence pack attached.

Step 3
Category

The Category We're Building: AI GxP

Validation software has mostly managed documents and workflow, and the established vendors are now adding AI too. We build around AI from the start, for validation, compliance and clinical documentation, with the assurance the draft Annex 22 points to.

AI GxP

AI applied to GxP-regulated processes, validated against the draft Annex 22.

GxP AI

AI products built for regulated work: assistants, agents and classifiers designed for GxP use.

Agentic Validation

AI agents draft and check the work; deterministic rules and people make the decisions.

Human-in-the-Loop Validation

AI drafts, humans decide. Named reviewers, segregation of duties, e-signature.

Clinical Documentation AI

Every sentence in a clinical draft linked back to its source data.

AI Computer System Validation

CSV where AI helps assemble the evidence, not just format it.

AI/ML System Validation

Model card, evaluation set, drift monitoring, human review and a fallback, aligned to the draft Annex 22.

Regulatory AI Systems

AI for regulatory intelligence, RIM and pharmacovigilance, with assurance built in.

FAQ

GxP & AI Validation FAQs

Prefer to talk first? Chat with us on WhatsApp or book a call with an expert.

What does Cybroscape Technologies do?

Cybroscape is an AI-first Life Sciences Validation, Regulatory Compliance and Clinical Technology company. We build AI products — GxP Copilot for validation, TraceDraft for clinical documentation — and deliver services across CSV, CSA, AI validation, medical writing, regulatory operations and AI transformation for pharma, biotech, medical device, CRO, diagnostics and healthcare-technology operators.

How is Cybroscape different from legacy validation vendors?

The established validation platforms are strong, configurable products with long track records, and they are adding AI too. Cybroscape starts from drafting: the validation package is drafted for your team to review and approve, test effort follows per-requirement risk, and Part 11 controls and AI governance are built in. It is priced for mid-sized teams that need regulated-grade validation without a large validation department.

Is GxP Copilot 21 CFR Part 11 compliant?

Yes. Electronic signatures include the ceremony 21 CFR Part 11 demands — including re-authentication at signing, meaning, name, timestamp and content binding. Authors cannot approve their own drafts. The audit trail is tamper-evident with an integrity check, and signed versions cannot be silently edited.

What is TraceDraft?

TraceDraft is our AI clinical documentation platform. It drafts Clinical Study Reports, protocols and amendments, Investigator Brochures, DSURs, IND annual reports, HAQ responses, IND packages, safety narratives and Clinical Evaluation Reports — with every sentence linked back to the source data behind it, a dedicated human review queue, and a tamper-evident audit trail.

Do you serve companies outside pharma?

Yes — we serve pharma, biotech, medical devices, CROs, diagnostics, vaccines, life sciences at large, and healthcare technology (SaMD and digital health).

How do you handle AI validation for GxP systems?

We follow the draft EU GMP Annex 22 (AI in GMP), which is still a consultation draft, and FDA's guidance on AI. We validate AI systems the way GxP demands: published model governance, an evaluation set that gates every release, safeguards on AI outputs, a human-in-the-loop policy, drift monitoring, and a documented fallback so the workflow keeps running with the AI switched off.

GxP Copilot — Product Overview (PDF)Download our one-page product overview to share with your QA head, CTO, or compliance team before the first call.

See your own URS become a validation package.

One real requirements document. We show you the draft package built from it, and you keep it either way.

  • We reply within one business day
  • We run your URS live on the call
  • You get a clear plan for your system

Book a demo

Four fields. The right specialist replies within one business day.

Your details stay private. We never share them.